Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth - Technavio

NEW YORK, Sept. 11, 2023 /PRNewswire/ -- The female sexual dysfunction treatment market size is expected to grow by USD 7.76 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 34.28% during the forecast period, according to Technavio Research. The market is segmented by age group (above 40 years and below 40 years),  Product (Non-hormonal therapy and Hormonal therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America will account for 61% of the global market share growth by 2027. The US is a leading country for regional market growth. Factors like the prevalence of breast cancer in the US were found to be 128.3 per 100,000 women and thus, the rising prevalence of chronic diseases will increase the risk and incidence of sexual dysfunction in women. This will drive market growth in the region during the forecast period. Additionally, an expected rise in the incidence of sexual dysfunction among women is expected to boost the demand for treatment. Hence, such factors are expected to increase the growth opportunities in the market in North America during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a PDF Sample Report

Company Profile:

Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddys Laboratories Ltd., Duchesnay Inc., Endo International Plc, Freya Pharma Solutions B.V., Lupin Ltd., Mithra Pharmaceuticals SA, Novo Nordisk AS, Palatin Technologies Inc., Pfizer Inc., Pharmbio Korea Inc., Sprout Pharmaceuticals Inc., Strategic Science and Technologies LLC, Teva Pharmaceutical Industries Ltd., Viatris Inc.

Pfizer - The company offers female sexual dysfunction treatment such as questionnaires and screeners. The company is engaged in the discovery, development, manufacturing, marketing, sales, and distribution of biopharmaceutical products worldwide.

•    To gain access to more vendor profiles available with Technavio, buy the report!

By Segment - The above 40 years segment will be significant during the forecast period. The segment growth can be attributed to the rising number of incidents of CVDs, diabetes, and cancer among the above 40 years age group. Moreover, the prevalence of chronic diseases in the segment is expected to increase the patient pool and hence the segment growth during the forecast period. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio

Female Sexual Dysfunction Treatment Market: Driver & Trend:

Driver

• Increasing prevalence of chronic diseases
• Growing awareness of female sexual dysfunction
• Approval and availability of drugs to treat hypoactive sexual desire disorder

The growing awareness of female sexual dysfunction is notably driving the market growth. A leading role is played by the International Society for Sexual Medicine in ensuring that the latest evidence-based scientific developments in sexual medicine reach the entire target audience of both male and female sexual health practitioners and patients around the world. It focuses on investing in improved communications and marketing with the goal of providing more awareness, appreciation, and support for sexual medicine/health. Similarly, W2O Group, in collaboration with the American Sexual Health Association, launched an education program called Find My Spark. Hence, such factors drive the growth of the female sexual dysfunction treatment market during the forecast period.

Strategic alliances among market vendors are a key trend in the female sexual dysfunction treatment market. Identify key trends, drivers, and challenges in the market. Download sample to gain access to this information.

Related Reports:

The sexual wellness market size is projected to increase by USD 46.47 billion and the market size is estimated to grow at a CAGR of 11.17% between 2022 and 2027. The market is segmented by product, distribution channel, and geography. The increasing number of sexual wellness initiatives and crowdfunding campaigns is the key factor that driving the growth of the market.

The sexual enhancement supplements market size is estimated to grow at a CAGR of 10.58% between 2022 and 2027. The market size is forecast to increase by USD 835.06 million. This sexual enhancement supplements market report extensively covers market segmentation by distribution channel (offline and online), product (male and female), and geography (North America, Europe, Asia, and Rest of World (ROW)). The availability of supplements in multiple dosage forms is notably driving the market growth.

What are the key data covered in this female sexual dysfunction treatment market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the female sexual dysfunction treatment market between 2022 and 2027.
• Precise estimation of the female sexual dysfunction treatment market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the female sexual dysfunction treatment market across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of female sexual dysfunction treatment market vendors.

ToC:

Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by Age Group

Market Segmentation by Product

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis

Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio